Mauritania vs Mozambique: Average non-HDL cholesterol levels
Mauritania
3
in 2018
Mozambique
3
in 2018
Mauritania rank
146th
Mozambique rank
146th
Average non-HDL cholesterol levels over time
- Mauritania
- Mozambique
How they compare
Mauritania currently reports 3 against 3 in Mozambique, a difference of 0.
The two have swapped places 1 time across 39 shared years of data; in 1980 it was Mauritania ahead.
Mauritania ranks 146th and Mozambique ranks 146th of 191 countries.
Mauritania has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Mauritania | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.71 | 2.47 | 0.24 | Mauritania |
| 1990s | 2.83 | 2.66 | 0.17 | Mauritania |
| 2000s | 2.9 | 2.76 | 0.14 | Mauritania |
| 2010s | 3 | 2.91 | 0.0889 | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, Mauritania or Mozambique?
- Mauritania, at 3 against 3 in Mozambique as of 2018.
- What is the difference in average non-hdl cholesterol levels between Mauritania and Mozambique?
- 0, with Mauritania ahead.
- How many years of comparable data are there for Mauritania and Mozambique?
- 39 years are reported by both, from 1980 to 2018.
- How do Mauritania and Mozambique rank globally for average non-hdl cholesterol levels?
- Mauritania ranks 146th and Mozambique ranks 146th of 191 countries.
- Where does this data come from?
- World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.